NFKB1 and early-onset autosomal dominant Alzheimer disease: On the other hand, we identified a reduction in transcripts linked to the nuclear factor‐kappa B (NF‐κB) signaling pathway (Figure 6C,D), suggesting the implication of sEH inhibition reducing neuroinflammation in this early onset Alzheimer disease (EOAD) mouse model.